Malaria against cancerous tumors
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Danish biomedicists made a sensational statement - they managed to find a cure for cancer, one of the main problems of our century. The discovery was made by accident - during studies related to the development of a malaria vaccine, scientists found that malarial proteins, if processed in a certain way, can destroy cancer cells, while quite effectively. Such special malarial proteins can destroy more than 90% of atypical cells, which slowly kill the human body. Oncologists will test a new cancer drug on volunteers over the next few years.
Research work was carried out by a group of scientists at the University of Copenhagen, in addition to the research institution, Mads Daugaard from Canada participated in the work. Experts tested the antimalarial vaccine for pregnant women and found out that the placenta contains a carbohydrate, attracting a malarial parasite, and its structure is similar to that found in cancer cells.
In their report, scientists explained that in the placenta this carbohydrate is responsible for accelerated growth, but at the same time the same carbohydrate promotes the growth of a cancerous tumor in the body.
During the study, the scientists found that a malarious parasite attacks an oncological tumor and is immediately attracted to the carbohydrate.
In the course of further work, it was found that if you combine toxin with malarial protein, then more than 90% of cancer cells of different types of tumors die - this is really impressive.
The specialists decided to test the drug that combines toxin with malarial protein in laboratory animals, which were transplanted to 3 different types of cancerous tumors: malignant lymphoma (non-Hodgkin's), bone cancer matting and prostate cancer.
As a result, the size of the tumor in rodents with lymphoma decreased by more than 75%, with bone cancer after 2 months, 5 of 6 rodents survived, and in 2 of 6 rodents with prostate cancer the cancer completely disappeared 4 weeks after taking the new drug . It is worth noting that all rodents from the control group who did not receive a new drug died after a while.
According to WHO, cancerous tumors lead to the death of most people (cancer is the leading cause of death in the world). And according to the researchers' forecasts, 70 years from the cancer will die by 70% more than today.
1/3 of all deaths from cancer are associated with 5 risk factors - obesity, sedentary lifestyle, smoking, drinking, nutrition (mainly a deficit in the diet of vegetables, fruits).
Now the specialists have to find out how effective the new treatment will be for a person. Also important is the calculation of the correct dosage of active substances. According to scientists, they intend to find out all these questions in their immediate experiments, but now one can say for sure that a new cancer drug is contraindicated during pregnancy, since the toxin, taking a placenta for a tumor (due to the similarity of the structure of carbohydrates), will destroy her.
[